Results 341 to 350 of about 788,696 (364)

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

Lancet, The, 2011
Salim Yusuf, Clara K Chow, Sumathy Rangarajan   +2 more
exaly  

Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis

Lancet, The, 2013
Joanne Katz, Anne C C Lee, Naoko Kozuki, Msph   +2 more
exaly  

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Lancet, The, 2016
Martin McKee, Clara K Chow, Sumathy Rangarajan   +2 more
exaly  

MIDDLE EAR

BMJ, 1960
openaire   +1 more source

Middle Ear Cholesterol Granuloma

Annals of Otology, Rhinology & Laryngology, 1991
J R, Kerstetter, K D, Dolan
openaire   +2 more sources

Cancer Control Opportunities in Low- and Middle-income Countries

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission

Lancet, The, 2013
Benoit Guery, Julien Poissy, Anne Goffard   +2 more
exaly  

Middle Ear

2010
Salvatore Iurato, Christian Martin, Oliver Sterkers, Wolfgang Arnold   +3 more
openaire   +1 more source

Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

New England Journal of Medicine, 2014
Salim Yusuf, Sumathy Rangarajan, Koon K Teo   +2 more
exaly  

Middle Ear

2015
John C. Carey, Albert H. Park
openaire   +1 more source